Aydogdu M, Trams G
Frauenklinik II des Zentralkrankenhauses, Bremen.
Geburtshilfe Frauenheilkd. 1996 Jan;56(1):60-2. doi: 10.1055/s-2007-1023251.
Angiosarcoma represents only 2.4% of soft tissue malignancies. Primary angiosarcoma of the breast is also a rare neoplasm. The incidence of this disease has been reported to be 0.04% of all breast malignancies. The aetiology is unknown. Angiosarcoma associated with chronic lymphoedematous arm of a postmastectomy woman was described by Stewart and Treves. In this paper we describe a 62-year-old female who underwent wide excision, axillary node dissection and adjuvant radiotherapy for primary breast cancer. After 5 years she noticed a purple discolouration of the treated left breast. Biopsy of these areas confirmed an angiosarcoma. No haematogenous dissemination was found. She underwent simple mastectomy without systemic therapy. A chest X-ray 3 months later revealed diffuse bilateral lung metastases. The incidence of breast conserving therapies is growing fast. Until now we have no evidence on the role of irradiation as an aetiological reason for angiosarcoma after breast-conserving surgery and axillary node dissection. Therefore, we have to pay increasing attention to these patients. A patient with history of radiotherapy after breast conserving therapy and skin discolouration must undergo a biopsy of these areas. The only therapy of angiosarcoma is an early mastectomy. The success of chemotherapy is uncertain. Possibly adjuvant chemotherapy with actinomycin D for the group with poorly differentiated tumours appears beneficial. Prospective studies might help to resolve this question.
血管肉瘤仅占软组织恶性肿瘤的2.4%。乳腺原发性血管肉瘤也是一种罕见的肿瘤。据报道,这种疾病的发病率占所有乳腺恶性肿瘤的0.04%。其病因尚不清楚。斯图尔特和特里夫斯描述了一名乳房切除术后女性慢性淋巴水肿手臂相关的血管肉瘤。在本文中,我们描述了一名62岁女性,她因原发性乳腺癌接受了广泛切除、腋窝淋巴结清扫和辅助放疗。5年后,她注意到接受治疗的左侧乳房出现紫色变色。对这些部位进行活检证实为血管肉瘤。未发现血行转移。她接受了单纯乳房切除术,未进行全身治疗。3个月后的胸部X光检查显示双侧肺弥漫性转移。保乳治疗的发生率正在迅速增长。到目前为止,我们没有证据表明放疗是保乳手术和腋窝淋巴结清扫术后血管肉瘤的病因。因此,我们必须越来越关注这些患者。有保乳治疗后放疗史且皮肤变色的患者必须对这些部位进行活检。血管肉瘤的唯一治疗方法是早期乳房切除术。化疗的成功率尚不确定。对于低分化肿瘤患者,使用放线菌素D进行辅助化疗可能有益。前瞻性研究可能有助于解决这个问题。